Please use this identifier to cite or link to this item:
https://hdl.handle.net/10216/127560Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Berto-Júnior, C | - |
| dc.creator | Carvalho, D | - |
| dc.creator | Soares, P | - |
| dc.creator | Miranda-Alves, L | - |
| dc.date.accessioned | 2020-06-18T11:12:21Z | - |
| dc.date.available | 2020-06-18T11:12:21Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.issn | 1664-2392 | - |
| dc.identifier.uri | https://hdl.handle.net/10216/127560 | - |
| dc.description.abstract | Zebrafish has been established as a reliable biological model with important insertion in academy (morphologic, biochemical, and pathophysiological studies) and pharmaceutical industry (toxicology and drug development) due to its molecular complexity and similar systems biology that recapitulate those from other organisms. Considering the toxicological aspects, many efforts using zebrafish models are being done in order to elucidate the effects of endocrine disruptors, and some of them are focused on tributyltin (TBT) and its mechanism of action. TBT is an antifouling agent applied in ship's hull that is constantly released into the water and absorbed by marine organisms, leading to bioaccumulation and biomagnification effects. Thus, several findings of malformations and changes in the normal biochemical and physiologic aspects of these marine animals have been related to TBT contamination. In the present review, we have compiled the most significant studies related to TBT effects in zebrafish, also taking into consideration the effects found in other study models. | - |
| dc.description.sponsorship | This study was supported by Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (PP-SUS-FAPERJ E-26/110.282/2014; JCNE-FAPERJ, E-26/201.520/2014; APQ1-FAPERJ, E-26/111.485/2014), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES/Ciências sem Fronteiras/Pesquisador Visitante Especial/88881.062218/2014-0), and Conselho Nacional de Desenvolvimento Científico (CNPq, PQ-Nível 2, 305872/2016-8). Funding was obtained from FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Operacional Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT-Funda??o para a Ci?ncia e a Tecnologia/Minist?rio da Ci?ncia, Tecnologia e Inova??o in the framework of the project "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274) and by the project "Advancing cancer research: from basic knowledgement to application"; NORTE-01-0145-FEDER-000029; Projetos Estruturados de I&D&I, funded by Norte 2020-Programa Operacional Regional do Norte. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript | - |
| dc.language.iso | eng | - |
| dc.publisher | Frontiers Research Foundation | - |
| dc.relation.ispartof | Frontiers in Endocrinology, vol.9:152 | - |
| dc.rights | openAccess | - |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
| dc.title | Tributyltin and Zebrafish: Swimming in dangerous water | - |
| dc.type | Artigo em Revista Científica Internacional | - |
| dc.contributor.uporto | Instituto de Investigação e Inovação em Saúde | - |
| dc.identifier.doi | 10.3389/fendo.2018.00152 | - |
| dc.relation.publisherversion | https://www.frontiersin.org/articles/10.3389/fendo.2018.00152/full | - |
| Appears in Collections: | I3S - Artigo em Revista Científica Internacional | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 10.3389-fendo.2018.00152.pdf | 738.04 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License
